Clover Health Investments Income Statement (2019-2026) | CLOV

Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
412.47M203.66M432.04M278.17M268.50M856.82M-1493.03M317.09M314.38M306.03M312.38M341.72M356.26M330.99M336.96M462.33M477.62M496.65M485.87M744.19M
Cost of Revenue (Quarter)
458.50M861.72M858.79M839.80M-1567.23M274.79M244.26M235.78M249.75M265.16M248.35M249.77M243.04M353.44M377.99M423.47M413.50M589.65M
Gross Profit (Quarter)
-46.03M203.66M432.04M-583.55M-590.28M17.02M74.21M42.30M70.12M70.24M62.63M76.56M107.91M81.21M93.92M108.89M99.63M73.18M72.37M154.54M
Operating items
Amortization - Intangibles (Quarter)
-0.01M
Selling, General & Administrative (Quarter)
45.65M45.85M55.18M57.70M47.04M47.83M51.11M57.64M41.71M41.03M42.70M44.57M44.42M35.20M52.29M50.67M48.48M48.95M66.16M74.63M
Other Operating Expenses (Quarter)
548.69M530.57M563.65M904.16M902.39M883.08M-1510.09M344.05M307.31M298.61M332.81M325.06M304.65M304.57M306.12M412.93M439.69M472.07M470.87M647.23M
Operating Expenses (Quarter)
594.33M576.42M618.83M961.86M949.43M930.91M-1458.98M401.69M349.02M339.64M375.52M369.62M349.07M339.77M358.41M463.61M488.18M521.03M537.03M721.86M
Operating Income (Quarter)
-181.86M-149.25M-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M
EBIT (Quarter)
-181.86M-149.25M-186.79M-87.48M-102.73M-74.10M-22.36M-79.70M-28.88M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M
Non-operating items
Non Operating Investment Income (Quarter)
12.39M-1.23M-0.98M-0.97M-4.73M-0.47M
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
Net income details
EBT (Quarter)
-183.07M-149.66M-187.19M-87.88M-103.12M-74.50M-22.50M-79.70M-28.89M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M
Profit After Tax (Quarter)
-317.61M-34.53M-187.20M-75.49M-104.36M-75.49M0.76M-72.61M-28.89M-33.62M-71.16M-19.17M7.41M-9.15M-22.09M-1.27M-10.58M-24.38M-49.32M27.33M
Income from Continuing Operations (Quarter)
-183.07M-149.66M-187.19M-87.88M-103.12M-74.50M-22.50M-79.70M-28.89M-33.62M-63.13M-22.70M7.19M-8.79M-21.45M-1.27M-10.56M-24.38M-49.32M27.33M
Consolidated Net Income (Quarter)
-183.07M-149.66M-187.19M-87.88M-103.12M-74.50M-22.50M7.09M0.07M-7.85M-2.51M4.00M0.24M-0.37M-0.57M27.33M
Income towards Parent Company (Quarter)
-183.07M-149.66M-187.19M-87.88M-103.12M-74.50M-22.50M7.09M0.07M-7.85M-2.51M4.00M0.24M-0.37M-0.57M27.33M
Net Income towards Common Stockholders (Quarter)
-183.07M-149.66M-187.19M-87.88M-103.12M-74.50M-22.50M7.09M0.07M-7.85M-2.51M4.00M0.24M-0.37M-0.57M27.33M
Additional items
EPS (Basic) (Quarter)
-0.78-0.08-0.44-0.16-0.22-0.160.01-0.17-0.06-0.07-0.14-0.050.01-0.02-0.04-0.02-0.05-0.100.05
EPS (Weighted Average and Diluted) (Quarter)
-0.78-0.08-0.44-0.16-0.22-0.160.01-0.17-0.06-0.07-0.14-0.050.01-0.02-0.04-0.02-0.05-0.100.05
Shares Outstanding (Weighted Average) (Quarter)
408.16M410.42M412.92M473.03M476.06M475.61M476.24M478.81M479.16M480.77M482.18M486.37M487.48M488.50M490.02M497.06M509.04M510.19M511.97M522.18M
Shares Outstanding (Diluted Average) (Quarter)
408.16M410.42M412.92M473.03M474.55M477.69M476.24M478.81M479.82M480.77M482.18M486.37M487.58M488.50M490.02M497.06M509.04M510.19M511.97M532.50M
EBITDA (Quarter)
-317.54M-34.72M-188.53M-80.81M-105.46M-77.90M-82.84M-70.26M-28.50M-39.83M-67.77M-19.36M7.71M-6.04M-24.53M0.24M-10.33M-24.08M-49.26M26.13M
Interest Expenses (Quarter)
1.21M0.40M0.40M0.40M0.39M0.40M0.14M0.01M